PRECISION BIOSCIENCES INC (DTIL) Operating margin 2018–2025
PRECISION BIOSCIENCES INC (DTIL) operating margin by fiscal year — reported operating income divided by reported revenue.
-152.2%FY2025 · since FY2018: -440.2% → -152.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -152.2% | -114.1 pp |
| FY2024 | -38.1% | +51.7 pp |
| FY2023 | -89.8% | +158.5 pp |
| FY2022 | -248.3% | -214.2 pp |
| FY2021 | -34.1% | +418.2 pp |
| FY2020 | -452.2% | -60.1 pp |
| FY2019 | -392.1% | +48.1 pp |
| FY2018 | -440.2% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More DTIL financial trends
DTIL RevenueDTIL Net incomeDTIL Net marginDTIL Gross profitDTIL Gross marginDTIL Operating incomeDTIL Operating cash flowDTIL Free cash flowDTIL Capital expendituresDTIL Return on equityDTIL Stock buybacksDTIL Dividends paidDTIL Total assetsDTIL Total liabilitiesDTIL Shareholders’ equityDTIL overview →